Feb 14, 2019

Drug company raises price of pain reliever by 70%

Egalet, a small pharmaceutical company, has raised the list price of its pain reliever and anti-inflammatory drug, Zorvolex, by 70%. A 90-pill bottle of Zorvolex now has a price tag of $650, compared with $383 a year ago, according to Elsevier's Gold Standard Drug Database.

The big picture: The drug does not generate a lot of relative sales, but the move is indicative of the pricing power drug companies still have, especially when drugs change ownership. The 70% price hike went into effect Feb. 1 — the day after Egalet completed its acquisition of Iroko Pharmaceuticals, the company that had owned Zorvolex.

Details: Zorvolex's new list price, which was spotted by drug pricing data firm 46brooklyn Research, does not include rebates or discounts.

  • There is little data about sales of Zorvolex, a low-dose pain reliever that received FDA approval in 2013. Iroko canceled an initial public offering that year, before sales officially started.
  • Egalet agreed to acquire Iroko last year, and the resulting company is going through the bankruptcy protection process.
  • Egalet is pushing to increase the total revenue of its 6 drugs, including Zorvolex, to at least $80 million annually.
  • A new sales team "will target pain medicine physicians, primary care physicians, nurse practitioners, orthopedic surgeons and neurologists in the United States with the intent to build awareness and increase adoption of" its drugs, according to a bankruptcy proceeding plan.

The bottom line: Egalet significantly raised the price of a brand-name drug that has generic equivalents right after it bought the drug, and as it prepares to persuade doctors to prescribe more of the drug.

  • Egalet did not respond to multiple phone calls and emails.

Go deeper

Older candidates take the lead on social media

Illustration: Eniola Odetunde/Axios

Michael Bloomberg, Bernie Sanders and Joe Biden — all close to 80 — are pushing the boundaries on social media, while their younger Democratic presidential rivals are comparatively staying out of the fray.

The big picture: President Trump's unexpected rise to political power has shown Democrats and world leaders the power of harnessing popular internet culture to get elected.

South Korea and Italy step up emergency measures as coronavirus cases jump

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's Health Ministry. Note: China numbers are for the mainland only and U.S. numbers include repatriated citizens.

The novel coronavirus has spread to more nations as South Korea and Italy step up emergency measures in their countries amid rising case numbers on Sunday.

The big picture: COVID-19 has killed at least 2,462 people and infected almost 79,000 others, mostly in mainland China. South Korea increased the infectious disease alert to red, the highest possible, as its case numbers jumped to 602 and the death toll to five. Italy's government announced emergency measures, with several towns in the north effectively placed in lockdown, as it confirmed two deaths and infections rose to 79.

Go deeperArrowUpdated 4 hours ago - Health

Bernie Sanders wins Nevada caucus

Democratic presidential candidate Sen. Bernie Sanders waves to supporters at a campaign rally on Friday in Las Vegas. Photo: Mario Tama/Getty Images

Sen. Bernie Sanders is projected to handily win the Nevada Democratic primary caucus, becoming the clear frontrunner among 2020 Democratic presidential primary election candidates.

Why it matters: Nevada is the first state with a diverse population to hold a nominating contest, highlighting candidates' abilities to connect with voters of color — particularly Latino voters.

Go deeperArrowUpdated 4 hours ago - Politics & Policy